Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 18, 2015 5:22 AM ET

Capital Markets

Company Overview of Sofinnova Ventures, Inc.

Company Overview

Sofinnova Ventures, Inc. is a venture capital firm specializing in seed, startup, early stage, series A, first venture round, and corporate spinouts. It also considers investments in intermediate and later stage startup companies. The firm does not invest in healthcare services, tool-kit companies, diagnostics, and neutraceuticals. It seeks to invest in life sciences and information technology sectors. In life sciences sector, it seeks to invest in clinical stage pharmaceutical products companies, biotechnology, therapeutic drug or product companies in the late preclinical or Phase I clinical stage, drug companies to treat diseases with unmet medical needs, drug discovery platform technology...

140 Geary Street

10th Floor

San Francisco, CA 94108

United States

Founded in 1974

Phone:

415-228-3380

Fax:

415-228-3390

Key Executives for Sofinnova Ventures, Inc.

Founding Partner
Founder and Managing Partner
Age: 39
Chief Financial Officer and Partner
General Partner, Managing Partner, and Partner
Age: 49
General Partner
Age: 59
Compensation as of Fiscal Year 2014.

Sofinnova Ventures, Inc. Key Developments

aTyr May Go For IPO

A big venture round led by Sofinnova Ventures, Inc. and backed by a lengthy string of biotech stalwarts and public investment firms is bound to get tongues wagging again about a possible IPO in the near future for aTyr Pharma Inc.

Sofinnova Ventures, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015 03:30 PM

Sofinnova Ventures, Inc. Presents at Biocom's Global Life Science Partnering Conference, Feb-25-2015 03:30 PM. Venue: The Lodge at Torrey Pines, 11480 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: David S. Kabakoff, Executive Partner and Partner at Sofinnova Venture Partners VIII.

Sofinnova Ventures Appoints Daniel G. Welch to Executive Partner

Sofinnova Ventures announced that Daniel G. Welch, former CEO of InterMune, has joined the Sofinnova team as an Executive Partner. Welch has a distinguished track record as a biotech executive, with over 30 years of experience across both multi-national pharmaceutical companies and biotech companies. Most recently, he was the Chairman, CEO and President of InterMune.

Similar Private Companies By Industry

Company Name Region
American Trust Retirement Planning Services United States
C P Management, L.L.C. United States
OPN Capital Markets, Inc. United States
Cleland Woolworth Capital Group, LLC United States
Roulston Research United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 6, 2015
Natera, Inc.
Private Placement
April 6, 2015
Edge Therapeutics, Inc.
Private Placement
March 31, 2015
aTyr Pharma Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Sofinnova Ventures, Inc., please visit www.sofinnova.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.